--- title: "Antleron & QbD team up to create a landslide in healthcare" description: "A whole new era in healthcare is coming closer every day. Thanks to the crossover of 3D printing and biology, medical solutions will be personalized like never before. It’s a matter of time till we can print body parts, organs, and medicines. At the forefront of this evolution is [Antleron](https://www.antleron.com/): an innovative and dynamic team that’s ready to make a mark. Well, that sounds like just the right match for QbD Group!" url: https://qbdgroup.com/en/blog/antleron-qbd-team-up-to-create-a-landslide-in-healthcare type: "Blog post" language: en published: 2017-05-10 author: "Martijn Reniers" category: "Pharma & Biotech" publisher: "QbD Group" citation: "QbD Group, \"Antleron & QbD team up to create a landslide in healthcare\", https://qbdgroup.com/en/blog/antleron-qbd-team-up-to-create-a-landslide-in-healthcare" --- # Antleron & QbD team up to create a landslide in healthcare > A whole new era in healthcare is coming closer every day. Thanks to the crossover of 3D printing and biology, medical solutions will be personalized like never before. It’s a matter of time till we can print body parts, organs, and medicines. At the forefront of this evolution is [Antleron](https://www.antleron.com/): an innovative and dynamic team that’s ready to make a mark. Well, that sounds like just the right match for QbD Group! Some encounters have big consequences. When QbD’s CEO **Bart Van Acker** met Antleron co-founder **Jan Schrooten** at a _Flanders.bio_ event, one thing soon led to another. Though both companies have their characteristics, they both share the ambition to push healthcare forward and make a difference for patients worldwide. Antleron’s motto **‘engineering life’** says it all. This innovative gang of engineers taps into the huge potential of 3D printing and blends it with the world of biomaterials, biologics, cells, and bioreactors. In doing so, they aim to create life-changing solutions in healthcare. “Together with QbD, we want to build an **ecosystem** in which we can jointly do what no one has done before”, Jan explains, “Our research and development matches perfectly with QbD’s tools, skills, and network.” In other words: QbD can help to turn Antleron’s ‘wild’ ideas into reality. That’s the good thing about this partnership: both companies complement one another in every way – going from scale to competencies – while sharing the same vision of **tomorrow’s medical world**. ## Printing billions of cells A landslide in healthcare: that’s what QbD and Antleron are going for. What these two companies want to achieve together, is the **opposite of the one-size-fits-all approach** we often see in medicine today. Every patient now gets the same medicine – in a bigger or smaller dose, but nevertheless. In the future, your pharmacist will print your specific medicine on the spot. And then there’s the **printing with human cells**. That sounds like no small feat. However, it’s mere logic, says Jan: “In fact, human cells are nothing more and nothing less than powerful, living building blocks. And you can use them as a raw material for printing personalized body parts or organs. However, we’ll need to know what exactly we want to print.” It will take a least ten to twenty years before we can 3D-print fully functional organs. “At first, that will be feasible for more simple organs like a liver,” Jan continues, “But whether it will one day be possible to create a functional heart or brain, remains to be seen. In five years, we’ll probably be able to print skin or cartilage tissue. However, we will need to build the capacity to process billions of cells at once to bring this technology into the clinic and make a difference for patients. We still have a very long way to go, in that regard.” ## Personalised healthcare solutions for all This kind of personalized medical solution wouldn’t only serve the happy few. QbD Group and Antleron want to put them **within the reach of everyone**. “It shouldn’t be something exclusive”, Jan emphasizes, “We want to create the processes and infrastructure to turn it into standard medical practice. You should be able to put a table next to every patient’s bed and print a living spare part for his or her body needs.” Of course, **many steps** still need to be taken. Not only scientifically, but also economically, legally, and even ethically. > “The question is whether society is ready for these advanced therapies, as they often require a certain mind switch. It’s something every kind of innovation has to go through. Together we can also face these challenges.” - Bart Van Acker, CEO at QbD Group ## Sharing the same vibe Knowhow and business aside, it’s clear that Antleron and QbD **share a strong vibe** to make their mark. Bart: “We both have that openness to fresh views and sharing ideas to make wonderful things happen.” “It’s easier to make your mark when it really clicks”, Jan adds, “You know what they say: great minds think alike … and sometimes have a drink together! _(laughs)”_ _[](https://qbdgroup.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJnI04EgVCqTcfVBit9Or%2BeQlDOTpLNO1pAlmE7GCmBXa9bFa5CuipsNw5Ot4BEfaUC6RyX%2BrdjJj8NSPzDnkzRcZaAYHf%2BMElv9C0FaxHhN3EYiMzsMMxrI6t1rV7fk0ZHoDA6YVxPfELKvvcUapA%2F3IDalNzO5XyLEW%2BsE0B12Mm9raUG&webInteractiveContentId=185834036347&portalId=7030766)_ ![QbD General - Contact Us](https://jrtdedcfhvzaomneervp.supabase.co/storage/v1/object/public/blog-images/blog_posts/content/antleron-qbd-team-up-to-create-a-landslide-in-healthcare/QbD_General_-_Contact_Us.png) ## Get in touch today! --- Source: https://qbdgroup.com/en/blog/antleron-qbd-team-up-to-create-a-landslide-in-healthcare — © QbD Group. Quote freely with attribution and a link back.